Background Oral PrEP uptake remains limited in Latin America, even as new HIV diagnoses continue to rise, especially among sexual and gender minorities (SGM). Previous research has highlighted a preference for long-acting PrEP in the region. With the approval of long-acting injectable cabotegravir and recent results of lenacapravir for PrEP, understanding PrEP preferences is vital … Continue reading 1355 – Long-Acting PrEP Preference Among Brazilian Sexual and Gender Minorities: Key Influencing Factors